Adhesive Capsulitis

Comprehensive Clinical Guide: Adhesive Capsulitis (Frozen Shoulder)

Adhesive capsulitis, colloquially known as "frozen shoulder," is a complex, debilitating, and often poorly understood glenohumeral joint pathology characterized by the progressive restriction of both active and passive shoulder range of motion (ROM). As an expert clinical guide, this document serves to delineate the pathophysiology, clinical staging, and management protocols essential for orthopedic practitioners, physical therapists, and clinical specialists.

1. Introduction and Clinical Overview

Adhesive capsulitis is defined as a condition of uncertain etiology characterized by significant restriction of active and passive glenohumeral motion that occurs in the absence of known intrinsic shoulder disorders. The prevalence in the general population is estimated at 2% to 5%, with a notable predilection for patients between the ages of 40 and 60.

The clinical hallmark is the "capsular pattern" of restriction, where external rotation is most severely limited, followed by abduction and internal rotation. While often considered self-limiting, the natural history of the disease can span from 12 to 36 months, leading to significant functional impairment and psychosocial distress for the patient.

2. Pathophysiology and Technical Mechanisms

The fundamental mechanism of adhesive capsulitis involves fibroproliferative changes within the glenohumeral joint capsule. Unlike simple synovitis, this condition involves a transformation of fibroblasts into myofibroblasts, leading to the deposition of excessive type I and type III collagen.

The Cellular Cascade

1. Inflammatory Phase: Initial cytokine-mediated inflammation (specifically TNF-alpha and IL-1) leads to synovial hypertrophy and hypervascularity.
2. Proliferative Phase: Fibroblastic proliferation occurs in the subacromial space and the axillary recess (the "rotator interval").
3. Fibrotic Phase: Dense collagenous tissue replaces synovial tissue, resulting in the characteristic thickening and contracture of the coracohumeral ligament and the inferior glenohumeral ligament (IGHL).

Anatomical Focus: The Rotator Interval

The rotator interval—the anatomical space between the supraspinatus and subscapularis tendons—is the primary site of pathology. Contracture in this region effectively "tethers" the humeral head, preventing the normal arthrokinematics of the glenohumeral joint during elevation.

3. Clinical Staging (The Reeves Classification)

Understanding the staging of adhesive capsulitis is critical for determining appropriate therapeutic interventions.

4. Differential Diagnosis

Because "frozen shoulder" is a diagnosis of exclusion, clinicians must systematically rule out pathologies that mimic capsular restriction.

• Glenohumeral Osteoarthritis: Typically presents with crepitus and radiographic evidence of joint space narrowing/osteophytes.
• Rotator Cuff Tears: Characterized by weakness (rather than just stiffness) and a positive "drop arm" test.
• Calcific Tendinopathy: Often presents with acute, severe pain and distinct radiographic calcifications in the supraspinatus tendon.
• Referred Pain: Cervical radiculopathy (C5-C6) must be ruled out via Spurling’s maneuver or neurological examination.
• Neoplasia: Pancoast tumors (superior sulcus tumors) can mimic shoulder pain and should be considered in patients with unexplained weight loss or progressive neurological deficits.

5. Diagnostic Testing and Clinical Assessment

Physical Examination Findings

• Passive ROM Testing: Essential for distinguishing capsular restriction from muscular weakness.
• The "End-Feel": Adhesive capsulitis classically presents with a firm, "leathery" end-feel at the limit of movement.
• GIRD (Glenohumeral Internal Rotation Deficit): Assessment of the posterior capsule.

Imaging Modalities

1. Radiography (X-Ray): Generally normal in adhesive capsulitis; used primarily to rule out GH osteoarthritis or bony lesions.
2. MRI/MRA (Magnetic Resonance Arthrography): Gold standard for visualizing the rotator interval. Findings include:
   • Thickening of the coracohumeral ligament (>4mm).
   • Obliteration of the subcoracoid fat triangle.
   • Axillary pouch thickening.
3. Ultrasound: Useful for evaluating synovial thickening and increased vascularity (Doppler flow) during the early freezing stage.

6. Management Protocols and Therapeutic Interventions

Management is dictated by the stage of the condition.

Conservative Management

• Pharmacotherapy: NSAIDs for initial inflammatory control; intra-articular corticosteroid injections are highly effective in the freezing stage (Stage 2) to reduce pain and improve early ROM.
• Physical Therapy: Focus on low-load, long-duration stretching. Aggressive manipulation is contraindicated during the inflammatory phase (Stage 1/2) as it may exacerbate synovial irritation.
• Hydrodilatation: The injection of saline and local anesthetic (often with a corticosteroid) into the glenohumeral joint to stretch the capsule from within.

Surgical Intervention

Reserved for patients who fail 6 months of conservative management:
* Manipulation Under Anesthesia (MUA): Passive force is applied to break capsular adhesions.
* Arthroscopic Capsular Release: Targeted surgical release of the coracohumeral ligament and the inferior glenohumeral ligament.

7. Risks, Contraindications, and Prognosis

Risks of Intervention

• MUA: Risk of humerus fracture, labral tear, or brachial plexus neurapraxia.
• Injections: Risk of infection (septic arthritis), though rare, and localized subcutaneous atrophy from corticosteroids.

Long-Term Prognosis

While the prognosis is generally favorable, approximately 10–15% of patients experience residual, long-term functional deficits. Recurrence in the contralateral shoulder occurs in approximately 20% of patients, while recurrence in the same shoulder is rare. Patients with underlying metabolic conditions, specifically Type 1 or Type 2 Diabetes Mellitus, often exhibit a more refractory clinical course and may require more aggressive intervention.

8. Frequently Asked Questions (FAQ)

1. Is adhesive capsulitis the same as a rotator cuff tear?

No. Adhesive capsulitis is a stiffness-dominant condition caused by capsular tightening. A rotator cuff tear is a structural failure of the tendons, primarily characterized by weakness and pain with active movement.

2. Can physical therapy make frozen shoulder worse?

Yes, if the intensity is too high during the acute inflammatory phase. "Aggressive" stretching during the freezing stage can increase inflammation and pain. Therapy should focus on pain-free mobilization.

3. Does diabetes affect the prognosis?

Yes. Diabetic patients are at a significantly higher risk (up to 20%) of developing adhesive capsulitis and often present with more severe, multi-joint involvement that is more resistant to standard treatments.

4. How long does the "freezing" phase last?

The freezing phase typically lasts between 3 to 9 months, characterized by a progressive and often severe increase in pain and loss of motion.

5. Are there any dietary changes that help?

While no specific diet cures adhesive capsulitis, managing systemic inflammation through an anti-inflammatory diet may support the management of the underlying synovial inflammation.

6. Will I ever regain full range of motion?

Most patients regain near-full function within 18–24 months. However, some minor loss of terminal external rotation may persist in a small percentage of patients.

7. Is surgery the first line of treatment?

Absolutely not. Surgery is reserved for cases that remain symptomatic after 6 months of structured, conservative management.

8. Can I exercise through the pain?

You should exercise within a "pain-free" window. Pushing through sharp, intense pain is counterproductive and may trigger further inflammatory cycles.

9. Why is the axillary recess important?

The axillary recess is a redundant fold of the capsule that unfolds during shoulder abduction. In adhesive capsulitis, this recess becomes obliterated by fibrosis, physically preventing the arm from being raised.

10. Does weather affect adhesive capsulitis?

Many patients report increased stiffness during cold or damp weather, likely due to changes in muscle tone and peripheral blood flow, though this is anecdotal rather than a primary diagnostic criterion.

9. Conclusion for the Specialist

Adhesive capsulitis remains a diagnostic challenge that requires a nuanced approach. The transition from inflammatory synovitis to fibrotic contracture mandates a shift in treatment strategy from pain management to mechanical remodeling. By maintaining a high index of suspicion for metabolic comorbidities and utilizing diagnostic imaging to confirm capsular thickening, the clinician can effectively navigate the patient through the stages of this condition, ultimately restoring functional independence.

Disclaimer: This guide is for educational purposes for healthcare professionals and does not replace institutional clinical protocols or individual patient assessment.